Market Place
Sourcing Support
Rosen Law Urges INO Investors with $100K+ Losses to Contact Firm
07 Apr 2026 //
PHARMIWEB
Robbins LLP Alerts Inovio Pharma Investors Of Class Action
20 Mar 2026 //
PHARMIWEB
INOVIO To Join Future Scientific & Investor Conferences
12 Feb 2026 //
PR NEWSWIRE
Inovio Reports Inducement Grant Under Inducement Plan
31 Oct 2025 //
PR NEWSWIRE
Inovio to Present at H.C. Wainwright Global Investment Conference
25 Aug 2025 //
PR NEWSWIRE
INOVIO`s Q2 2025 Financial Results and Business Highlights
12 Aug 2025 //
PR NEWSWIRE
Inovio Pharma to Present at Upcoming Scientific Conference
07 Jul 2025 //
PR NEWSWIRE
INOVIO Reports 2024 Financial Results and Highlights
18 Mar 2025 //
PR NEWSWIRE
Inovio Highlights Anticipated 2025 Milestones & Key Accomplishments
09 Jan 2025 //
PR NEWSWIRE
INOVIO Reports Inducement Grant Under Inducement Plan
29 Nov 2024 //
PR NEWSWIRE
Inovio Receives EMA Certificate For INO-3107 Quality And Non-Clinical Data
25 Jul 2024 //
PR NEWSWIRE
INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
02 Jul 2024 //
PR NEWSWIRE
INOVIO Added to Russell 2000® Index Effective July 1, 2024
01 Jul 2024 //
PR NEWSWIRE
Inovio Reports Inducement Grant Under Inducement Plan
01 Jul 2024 //
PR NEWSWIRE
Inovio Pharma stock underperforms Tuesday when compared to competitors
12 Mar 2024 //
MARKETWATCH
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
08 Mar 2024 //
MARKETWATCH
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
PR NEWSWIRE
INOVIO Reports Inducement Grant Under Inducement Plan
02 Feb 2024 //
PR NEWSWIRE
INOVIO and Coherus Announce Clinical Collaboration
04 Jan 2024 //
PR NEWSWIRE
Inovio says no-go on phase 3 program, lays off 30% of staff
10 Aug 2023 //
FIERCE BIOTECH
Inovio prunes headcount again; Aulos adds to Series A
01 Aug 2023 //
ENDPTS
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder
23 Jun 2023 //
GLOBENEWSWIRE
Inovio drops Lassa, MERS vaccines as clinical data fall short
19 Nov 2022 //
FIERCEPHARMA
INOVIO Provides an Update on Lassa Fever and MERS Programs
17 Nov 2022 //
PRNEWSWIRE
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022
08 Nov 2022 //
PRNEWSWIRE
Inovio to stop Covid-19 heterologous booster vaccine development
28 Oct 2022 //
CLINICALTRIALSARENA
INOVIO Provides Update on COVID-19 Booster Vaccine Candidate, INO-4800
27 Oct 2022 //
PRNEWSWIRE
INOVIO to Report Third Quarter 2022 Financial Results on November 8, 2022
25 Oct 2022 //
PRNEWSWIRE
INOVIO Reports Positive Interim Phase 1/2 Results for INO-3107
13 Oct 2022 //
PRNEWSWIRE
1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals
11 Sep 2022 //
FOOL
INOVIO Reports Inducement Grants Under Inducement Plan
01 Sep 2022 //
PRNEWSWIRE
INOVIO to Present at the H.C. Wainwright Annual Global Investment Conference
30 Aug 2022 //
PRNEWSWIRE
Inovio agrees to shell out $44M to settle Covid-19 vaccine lawsuit
25 Aug 2022 //
ENDPTS
INOVIO Reports Financial Results and Highlights for the Second Quarter 2022
09 Aug 2022 //
PRNEWSWIRE
INOVIO to Report Second Quarter 2022 Financial Results on August 9, 2022
26 Jul 2022 //
PRNEWSWIRE
Inovio to cut 18% full-time jobs to conserve cash
20 Jul 2022 //
REUTERS
INOVIO Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01 Jul 2022 //
PRNEWSWIRE
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
27 Jun 2022 //
PRNEWSWIRE
INOVIO Announces Survival Results for INO-5401 + INO-9012 with Libtayo
27 May 2022 //
PRNEWSWIRE
INOVIO to Present at Jefferies 2022 Healthcare Conference
23 May 2022 //
PRNEWSWIRE
INOVIO Appoints Jacqueline Shea, Ph.D., as Chief Executive Officer
10 May 2022 //
PRNEWSWIRE
INOVIO Reports First Quarter 2022 Financial Results and Program Developments
10 May 2022 //
PRNEWSWIRE
Inovio Pharmaceuticals (INO) Q1 2022 Earnings Call Transcript
10 May 2022 //
NASDAQ
INOVIO to Present at Oppenheimer`s 32nd Annual Healthcare Conference
08 Mar 2022 //
PRNEWSWIRE
Inovio pauses COVID-19 vaccine trial, seeks endpoint switch
03 Mar 2022 //
FIERCEBIOTECH
Inovio collaborates with GuardRX, Geneva University Hospitals for INO-4201
18 Nov 2021 //
PHARMABIZ
INOVIO Collaborates with GuardRX and Geneva University Hospitals for INO-4201
16 Nov 2021 //
PRNEWSWIRE
INOVIO to Give Eight Presentations at the 34th International Papillomavirus
15 Nov 2021 //
PRNEWSWIRE
AstraZeneca scraps midphase drugs from $1B buyout, Heptares pact
13 Nov 2021 //
FIERCEBIOTECH
FDA lifts clinical hold on Inovio’s Phase III Covid-19 vaccine trial in US
10 Nov 2021 //
CLINICALTRIALSARENA
FDA lifts hold from Phase 3 trial of Inovio`s COVID-19 shot
10 Nov 2021 //
MARKETWATCH
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3
09 Nov 2021 //
PRNEWSWIRE
INOVIO Reports Third Quarter 2021 Financial Results
09 Nov 2021 //
PRNEWSWIRE
Inovio obtains approval for Phase III trial of Covid-19 vaccine in India
04 Nov 2021 //
CLINICALTRIALSARENA
INOVIO Expands Phase 3 Trial for COVID-19 DNA Vaccine Candidate INO-4800
03 Nov 2021 //
PRESS RELEASE
Inovio falls victim to AstraZeneca`s `usual pipeline pruning`
02 Nov 2021 //
FIERCEBIOTECH
Inovio signs MoU with Colombia to boost efforts to tackle Covid-19
22 Oct 2021 //
PHARMACEUTICAL-TECHNOLOGY
INOVIO Announces Collaboration with Colombia; Memorandum
21 Oct 2021 //
PRNEWSWIRE
Inovio Pharmaceuticals – Consensus Indicates Potential 91.0% Upside
13 Oct 2021 //
DIRECTORSTALKINTERVIEWS
Inovio extends Phase III trial of Covid-19 vaccine to Colombia
12 Oct 2021 //
CLINICALTRIALSARENA
